Atlas Venture

Atlas Venture

Cambridge, Massachusettsatlasventure.com

Overview

Atlas Venture is an early-stage venture capital firm that creates and invests in biotechnology startup companies in the United States.

Year Founded

1980

AUM

$2.4B

Portfolio Companies

65

Investments

CompanyDateStageLead
Obsidian TherapeuticsApr 2026Private PlacementCo-investor
Vima TherapeuticsMar 2026Series ACo-investor
Kinaset TherapeuticsJan 2026Series BCo-investor
Diagonal TherapeuticsJan 2026Series BCo-investor
TRIANA BiomedicinesDec 2025Series BCo-investor

Key People

Yi Sung Yong

Co-Founder

Maria G. Beconi

Scientific Advisor And Co-Founder Founder CEO. Stealth NewCo

Adam Atlas

Managing Partner

Alexander Bruehl

Until Mar 2008 Senior Partner

David Grayzel

Managing Director

Akshay Vaishnaw

Venture Partner

Doug Kerr

Venture Partner

Jeff Albers

Venture Partner

John Maraganore

Venture Partner

Linda Bain

Venture Partner

Robert Copeland

Venture Partner

Alyssa W.

Partner

André Luiz Maciel

Partner

Anna .

Partner

Bella Z.

Partner

Betty C.

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded1980
AUM$2.4B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.